EPISODE · Jul 2, 2024 · 28 MIN
Harnessing AI to Revolutionize Drug Discovery
In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.Resources:Amazon Bedrock: https://aws.amazon.com/bedrock/Amazon Q: https://aws.amazon.com/q/AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/
What this episode covers
In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.Resources:Amazon Bedrock: https://aws.amazon.com/bedrock/Amazon Q: https://aws.amazon.com/q/AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/
NOW PLAYING
Harnessing AI to Revolutionize Drug Discovery
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m